systematic biopsies

PROCEDURE2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Karolinska Institutet

Conditions

Prostate Cancer

Unknown Phase

Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.

CompletedNCT02050542

Assistance Publique - Hôpitaux de ParisProstate Cancer

Start: 2014-06-30End: 2015-02-28Updated: 2025-11-20

Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies

Active, not recruitingNCT03377881

Karolinska InstitutetProstate Cancer

Start: 2018-04-04End: 2030-12-10Updated: 2023-12-26

Related Papers

Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.

2026-06-23

Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening

JAMA Network Open2024-04-2217 citations

Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging

JAMA Network Open2024-02-0723 citations

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

JAMA Oncology2022-11-1043 citations

Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study.

2022-01-3115 citations

Novel Stockholm3 Test With MRI Enhances Prostate Cancer Screening

Oncology Times2022-01-03

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.

2021-08-13126 citations

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

New England Journal of Medicine2021-07-09349 citations

MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI.

Journal of Clinical Oncology2020-02-19

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

BMJ Open2019-06-0119 citations